159 related articles for article (PubMed ID: 28017826)
1. Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials.
Hos NJ; Jazmati N; Stefanik D; Hellmich M; AlSael H; Kern WV; Rieg S; Wisplinghoff H; Seifert H; Kaasch AJ
J Infect; 2017 Mar; 74(3):248-259. PubMed ID: 28017826
[TBL] [Abstract][Full Text] [Related]
2. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
3. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
[TBL] [Abstract][Full Text] [Related]
4. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method.
Wang JL; Wang JT; Sheng WH; Chen YC; Chang SC
BMC Infect Dis; 2010 Jun; 10():159. PubMed ID: 20529302
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.
Rojas L; Bunsow E; Muñoz P; Cercenado E; Rodríguez-Créixems M; Bouza E
J Antimicrob Chemother; 2012 Jul; 67(7):1760-8. PubMed ID: 22556382
[TBL] [Abstract][Full Text] [Related]
6. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
7. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH
J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187
[TBL] [Abstract][Full Text] [Related]
8. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.
Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC
J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999
[TBL] [Abstract][Full Text] [Related]
9. Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010.
Edwards B; Milne K; Lawes T; Cook I; Robb A; Gould IM
J Clin Microbiol; 2012 Feb; 50(2):318-25. PubMed ID: 22135252
[TBL] [Abstract][Full Text] [Related]
10. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.
Miller CE; Batra R; Cooper BS; Patel AK; Klein J; Otter JA; Kypraios T; French GL; Tosas O; Edgeworth JD
Clin Infect Dis; 2012 Mar; 54(5):591-600. PubMed ID: 22186774
[TBL] [Abstract][Full Text] [Related]
11. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
Honda H; Doern CD; Michael-Dunne W; Warren DK
BMC Infect Dis; 2011 Dec; 11():335. PubMed ID: 22142287
[TBL] [Abstract][Full Text] [Related]
12. Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.
Butterfield JM; Tsuji BT; Brown J; Ashley ED; Hardy D; Brown K; Forrest A; Lodise TP
Antimicrob Agents Chemother; 2011 Dec; 55(12):5433-7. PubMed ID: 21930887
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
Bland CM; Porr WH; Davis KA; Mansell KB
South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
[TBL] [Abstract][Full Text] [Related]
14. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
Kullar R; Davis SL; Levine DP; Rybak MJ
Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309
[TBL] [Abstract][Full Text] [Related]
15. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD
Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia.
Choi EY; Huh JW; Lim CM; Koh Y; Kim SH; Choi SH; Kim YS; Kim MN; Hong SB
Intensive Care Med; 2011 Apr; 37(4):639-47. PubMed ID: 21253703
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.
Musta AC; Riederer K; Shemes S; Chase P; Jose J; Johnson LB; Khatib R
J Clin Microbiol; 2009 Jun; 47(6):1640-4. PubMed ID: 19369444
[TBL] [Abstract][Full Text] [Related]
18. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.
van Hal SJ; Lodise TP; Paterson DL
Clin Infect Dis; 2012 Mar; 54(6):755-71. PubMed ID: 22302374
[TBL] [Abstract][Full Text] [Related]
19. High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.
Jacob JT; DiazGranados CA
Int J Infect Dis; 2013 Feb; 17(2):e93-e100. PubMed ID: 23089040
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
Uçkay I; Bernard L; Buzzi M; Harbarth S; François P; Huggler E; Ferry T; Schrenzel J; Renzoni A; Vaudaux P; Lew DP
Antimicrob Agents Chemother; 2012 Mar; 56(3):1258-64. PubMed ID: 22155824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
